ALBERTDAVDNSEAlbert David Limited· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Thu, 18 Dec, 2025 · 19:30 IST

Albert David MD and CEO Umesh Kunte resigns effective December 18

Ceo ResignedKmp ResignedManagement Changes View source PDFExplain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹744.20
prior close
₹747.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.3%-1.4% vs market
Pharmaceuticals peers, median of 153sector+0.7%-0.9% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+1.3-1.4+0.7-0.9
Next day
+0.9+2.6-1.7+1.3-0.4
2d
+0.8+2.7-1.9+1.4-0.7
3d
+0.8+2.1-1.4+1.4-0.7
4d
+0.9+1.6-0.7+0.7+0.2
5d
-0.6+0.8-1.4+0.0-0.6
1w
-0.7+2.2-2.9+0.7-1.4
15d
+0.4-1.6+2.0-1.1+1.5
1m
-7.3-3.0-4.2-1.8-5.5
2m
-4.0-1.6-2.4-3.9-0.1
3m
-9.8-10.5+0.6-10.2+0.4
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Albert David Limited has accepted the resignation of Mr. Umesh Manohar Kunte from the positions of Managing Director, CEO and Director effective from close of business on December 18, 2025. The resignation is due to personal reasons and priorities. Mr. Kunte will also cease to be a Key Managerial Person under Section 203 of the Companies Act 2013. His letter mentions a three month notice period. The company has placed on record its appreciation for his services.

Likely market impact

Top leadership vacuum at MD and CEO level. Watch for successor announcement; short term strategic uncertainty possible.